An HIV strain resistant to all proteaseinhibitor drugs currently on the market turns up in San Francisco.
在美国旧金山,发现了一种对现有市场上的所有蛋白酶抑制剂都耐药的HIV病毒株。
2
Combinations of a proteaseinhibitor with two nucleoside reverse transcriptase inhibitors are currently recommended for postexposure prophylaxis of relatively high-risk exposures.
对相对高危暴露,目前推荐用一个蛋白酶抑制剂结合两个逆转录酶抑制剂作暴露后预防治疗。
3
This article reviews the active mechanism and peculiarity of HCV NS3 proteaseinhibitor.